Description
Book SynopsisThis book gives an expert view of how the project management approach can be taken forward by the pharmaceutical industry over the next decade. The book integrates portfolio, program, and project management processes as fundamentals for effective and efficient drug product development.
Table of ContentsPreface ix
Acknowledgments xi
About the Authors xiii
Part One The Life Science Industry Context for Portfolio, Program, and Project Management
1. A Review of Project Management in Life Science Industry Sectors 3
Thomas R. Dunson
2. The Impact of Organizational Size on Drug Project Management 21
Eric Morfin
3. Drug Development in Biotechnology and How We Can Do It Better 33
Susan Linna
Part Two The Portfolio, Program, and Project Management Approaches and Processes
4. An Overview of the Organization and Processes of Portfolio, Program, and Project Management 53
Pete Harpum
5. Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market 59
John Bennett
6. Program Management in Drug Development 85
Pauline Stewart-Long
7. Project Control 101
Martin Powell
8. Managing Uncertainty in Drug Projects 135
Pete Harpum and Thomas R. Dunson
9. Managing Drug Safety Risk 155
Thomas R. Dunson and Eric Morfin
10. Developing Program Strategy 175
Pete Harpum
11. Developing Products with “Added Value” 197
Trevor J. Brown and Stephen Allport
Part Three Integrating the Processes
12. Integrated Business Processes to Support Cross-Functional Drug Development 227
Martin D. Hynes III
13. Integrated Drug Development: From Cradle to Grave and from Lab to Market 239
Stephen Allport and Terry Cooke-Davies
14. The Development of P3M Capability in Drug Development Organizations 259
John Arrowsmith, Patrick Grogan, and Bob Moore
15. Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations 287
Pete Harpum, Ashley Jamieson, and Inge Fisher
Bibliography 311
Index 313
